Alterations in BNST Intrinsic Functional Connectivity in Early Abstinence from Alcohol Use Disorder.


Journal

Alcohol and alcoholism (Oxford, Oxfordshire)
ISSN: 1464-3502
Titre abrégé: Alcohol Alcohol
Pays: England
ID NLM: 8310684

Informations de publication

Date de publication:
09 May 2023
Historique:
received: 19 08 2022
revised: 03 01 2023
accepted: 22 01 2023
pmc-release: 27 02 2024
medline: 11 5 2023
pubmed: 28 2 2023
entrez: 27 2 2023
Statut: ppublish

Résumé

Maintaining abstinence from alcohol use disorder (AUD) is extremely challenging, partially due to increased symptoms of anxiety and stress that trigger relapse. Rodent models of AUD have identified that the bed nucleus of the stria terminalis (BNST) contributes to symptoms of anxiety-like behavior and drug-seeking during abstinence. In humans, however, the BNST's role in abstinence remains poorly understood. The aims of this study were to assess BNST network intrinsic functional connectivity in individuals during abstinence from AUD compared to healthy controls and examine associations between BNST intrinsic functional connectivity, anxiety and alcohol use severity during abstinence. The study included resting state fMRI scans from participants aged 21-40 years: 20 participants with AUD in abstinence and 20 healthy controls. Analyses were restricted to five pre-selected brain regions with known BNST structural connections. Linear mixed models were used to test for group differences, with sex as a fixed factor given previously shown sex differences. BNST-hypothalamus intrinsic connectivity was lower in the abstinent group relative to the control group. There were also pronounced sex differences in both the group and individual analyses; many of the findings were specific to men. Within the abstinent group, anxiety was positively associated with BNST-amygdala and BNST-hypothalamus connectivity, and men, not women, showed a negative relationship between alcohol use severity and BNST-hypothalamus connectivity. Understanding differences in connectivity during abstinence may help explain the clinically observed anxiety and depression symptoms during abstinence and may inform the development of individualized treatments.

Identifiants

pubmed: 36847484
pii: 7058858
doi: 10.1093/alcalc/agad006
pmc: PMC10168710
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-307

Subventions

Organisme : National Institute of Alcohol Abuse and Alcoholism
ID : R21AA025385
Organisme : National Institute of Mental Health
ID : T32MH018921
Organisme : National Institute of General Medical Sciences
ID : T32GM007347
Organisme : Vanderbilt Institute for Clinical and Translational Research
ID : 1UL1TR002243-01

Informations de copyright

© The Author(s) 2023. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Références

Hum Brain Mapp. 2018 Mar;39(3):1367-1379
pubmed: 29266586
Neuropsychopharmacology. 2016 Jan;41(1):335-56
pubmed: 25976297
Addict Biol. 2015 Mar;20(2):407-14
pubmed: 24529072
Am J Drug Alcohol Abuse. 2013 Nov;39(6):433-40
pubmed: 24200213
Psychol Med. 2018 Apr;48(6):919-928
pubmed: 28826410
Diagn Interv Radiol. 2017 Sep-Oct;23(5):390-397
pubmed: 28870884
Hum Brain Mapp. 2018 Mar;39(3):1291-1312
pubmed: 29235190
Alcohol Clin Exp Res. 2017 Jan;41(1):107-116
pubmed: 27883214
Alcohol. 2016 Feb;50:19-25
pubmed: 26775553
Pharmacol Rev. 2016 Apr;68(2):242-63
pubmed: 26772794
Hum Brain Mapp. 2015 Oct;36(10):4076-88
pubmed: 26178381
Alcohol Clin Exp Res. 2021 May;45(5):1028-1038
pubmed: 33830508
Netw Neurosci. 2020 Sep 01;4(3):925-945
pubmed: 33615097
Hum Brain Mapp. 2021 Apr 15;42(6):1594-1616
pubmed: 33314443
Behav Res Ther. 1990;28(6):487-95
pubmed: 2076086
J Neurosci. 1999 Oct 15;19(20):RC35
pubmed: 10516337
Sci Rep. 2018 Nov 12;8(1):16702
pubmed: 30420682
ACS Chem Neurosci. 2018 Sep 19;9(9):2173-2187
pubmed: 29851347
Neuroimage. 2007 Aug 1;37(1):90-101
pubmed: 17560126
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
J Pharmacol Exp Ther. 2010 Jan;332(1):298-307
pubmed: 19843974
Eur J Pharmacol. 2001 Dec 7;432(2-3):153-61
pubmed: 11740951
Mol Psychiatry. 2016 Apr;21(4):450-63
pubmed: 26878891
Alcohol Res. 2012;34(4):448-58
pubmed: 23584111
Neuropsychopharmacology. 2016 Jan;41(1):126-41
pubmed: 26105138
Br J Addict. 1988 Apr;83(4):393-402
pubmed: 3395719
Pharmacol Biochem Behav. 2022 Apr;215:173360
pubmed: 35219756
Neuroimage. 2014 May 1;91:311-23
pubmed: 24444996
J Clin Psychiatry. 2006 Feb;67(2):247-57
pubmed: 16566620
Transl Psychiatry. 2018 Jan 31;8(1):33
pubmed: 29382815
J Consult Clin Psychol. 1988 Dec;56(6):893-7
pubmed: 3204199
J Neurosci. 2006 Nov 1;26(44):11442-53
pubmed: 17079674
eNeuro. 2018 Jul 2;5(3):
pubmed: 29971248
J Psychiatr Res. 2020 Mar;122:54-63
pubmed: 31927266
J Psychiatry Neurosci. 2019 Apr 09;44(5):313-323
pubmed: 30964612
Neuroimage. 2020 Apr 15;210:116555
pubmed: 31954845
Psychopharmacology (Berl). 2001 Dec;158(4):360-5
pubmed: 11797056
Alcohol Clin Exp Res. 2013 May;37(5):794-803
pubmed: 23421812
Cereb Cortex. 2013 Sep;23(9):2086-99
pubmed: 22819968
Neuropsychopharmacology. 2000 Aug;23(2):138-50
pubmed: 10882840
Psychopharmacology (Berl). 2006 Mar;185(1):19-28
pubmed: 16374599
Neuroimage. 2020 Feb 15;207:116428
pubmed: 31809887
J Anxiety Disord. 2007;21(1):105-17
pubmed: 16647833
Biol Psychiatry. 2010 Jun 15;67(12):1117-9
pubmed: 20525501
Brain Connect. 2012;2(3):125-41
pubmed: 22642651
J Neuroendocrinol. 2016 Dec;28(12):
pubmed: 27805752
Neuroimage. 2018 Mar;168:392-402
pubmed: 28392491
Brain Imaging Behav. 2021 Feb;15(1):25-35
pubmed: 31833015
Alcohol Clin Exp Res. 2021 Aug;45(8):1596-1606
pubmed: 34342012
Biol Psychiatry. 2013 Jan 1;73(1):85-92
pubmed: 22770651
Psychiatry Res. 2019 Aug;278:97-115
pubmed: 31174033
Neuropsychopharmacology. 2019 Feb;44(3):526-537
pubmed: 30390064
Alcohol Alcohol. 2010 Sep-Oct;45(5):437-43
pubmed: 20729530
J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1353-1360
pubmed: 31256001
Front Psychol. 2022 Mar 03;13:805049
pubmed: 35310241
Alcohol. 2019 Aug;78:57-68
pubmed: 30797833
J Neurosci. 2002 Jul 1;22(13):5713-8
pubmed: 12097523
Alcohol Clin Exp Res. 2007 Dec;31(12):2036-45
pubmed: 18034696
Neuron. 2017 Aug 16;95(4):791-807.e7
pubmed: 28757305
J Neurophysiol. 2010 Jan;103(1):297-321
pubmed: 19889849
Cereb Cortex. 2013 Jan;23(1):114-26
pubmed: 22267308
Mod Probl Pharmacopsychiatry. 1987;22:141-73
pubmed: 2885745
Neuroimage. 2017 Feb 1;146:288-292
pubmed: 27876653
Curr Neuropharmacol. 2013 Mar;11(2):141-59
pubmed: 23997750
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
J Neurosci. 2014 Sep 10;34(37):12504-14
pubmed: 25209288
Biol Psychiatry. 2015 Feb 1;77(3):276-284
pubmed: 24673881
Neuroimage. 2013 Dec;83:550-8
pubmed: 23747458
Handb Clin Neurol. 2021;180:149-160
pubmed: 34225926
Alcohol. 2015 Aug;49(5):435-52
pubmed: 26074423

Auteurs

Elizabeth A Flook (EA)

Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19104, USA.
Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN 37232, USA.
Vanderbilt Center for Addiction Research, Vanderbilt University, 2215 Garland Ave, Nashville, TN 37232, USA.

Brandee Feola (B)

Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, 1601 23rd Avenue South, Nashville, TN 37212, USA.

Margaret M Benningfield (MM)

Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN 37232, USA.
Vanderbilt Center for Addiction Research, Vanderbilt University, 2215 Garland Ave, Nashville, TN 37232, USA.
Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, 1601 23rd Avenue South, Nashville, TN 37212, USA.

Marisa M Silveri (MM)

Neurodevelopmental Laboratory on Addictions and Mental Health, Brain Imaging Center, McLean Hospital, 115 Mill St, Belmont, MA 02478, USA.
Department of Psychiatry, Harvard Medical School, 401 Park Drive, Boston, MA 02215, USA.

Danny G Winder (DG)

Vanderbilt Center for Addiction Research, Vanderbilt University, 2215 Garland Ave, Nashville, TN 37232, USA.
Department of Molecular Physiology and Biophysics, Vanderbilt University, 2215 Garland Avenue, Nashville, TN 37212, USA.
Department of Pharmacology, Vanderbilt University, 465 21st Avenue South, Nashville, TN 37240, USA.

Jennifer Urbano Blackford (JU)

Vanderbilt Center for Addiction Research, Vanderbilt University, 2215 Garland Ave, Nashville, TN 37232, USA.
Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, 1601 23rd Avenue South, Nashville, TN 37212, USA.
Munroe-Meyer Institute, University of Nebraska Medical Center, 6902 Pine Street, Omaha, NE 68106, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH